used in traditional Chinese, Ayurvedic, and Thai medication. Conolidine could depict the start of a fresh period of chronic soreness management. It is now getting investigated for its outcomes over the atypical chemokine receptor (ACK3). Inside a rat model, it was uncovered that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3